Delayed release pancreatin compositions
US9198871B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Aug 15, 2006 |
| Grant date | Dec 1, 2015 |
| Priority date | — |
| Expiry date | Feb 7, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y304/21004
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An enteric-coated oral dosage form comprising an acid labile active pharmaceutical ingredient where the composition is substantially free of monomeric phthalic acid esters and synthetic oils is described herein. Also provided are methods for making and using the enteric-coated oral dosage form. The disclosed pharmaceutical compositions comprise an enteric coating which includes at least one plasticizer, at least one film-forming agent and optionally at least one anti-sticking agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.